Click here to view the Humana Medical Policy Updates Updates » September 2024 Humana Medical…
BCBS Mississippi Medical Policy Updates – February 2023
Click here to view the Blue Cross Blue Shield BCBS Mississippi Medical Policy Updates »
February 2023 BCBS Mississippi Medical Policy Updates:
- Ablation Procedures for Peripheral Neuromas
- ACL Inhibitors and Combinations
- Acute and Maintenance Tocolysis
- Adakveo (crizanlizumab-tmca)
- Aduhelm (aducanumab)
- Akynzeo (netupitant and palonosetron)
- Albenza (albendazole)
- Allergy Tests of Uncertain Efficacy
- Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms
- Alpha-1 Proteinase Inhibitors
- Amitiza (lubiprostone)
- Amniotic Membrane and Amniotic Fluid Injections
- Amyotrophic Lateral Sclerosis (ALS)
- Anabolic Steroids
- Analysis of Proteomic Patterns for Early Detection of Cancer
- Anjeso (meloxicam)
- Anti-Rheumatic Biologicals
- Anzemet/Kytril Injection
- Apokyn® (Apomorphine Hydrochloride)
- Arthroscopic Debridement and Lavage as Treatment of Osteoarthritis of the Knee
- Atypical Antipsychotics
- Autologous Hematopoietic Stem-Cell Transplantation for Malignant Astrocytomas and Gliomas
- Benlysta (belimumab)
- Bioengineered Skin and Soft Tissue Substitutes
- Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Breast Cancer
- Cabenuva (cabotegravir and rilpivirine)
- Cablivi (caplacizumab-yhdp)
- Cerebrospinal Fluid and Urinary Biomarkers of Alzheimer Disease
- Chimeric Antigen Receptor Therapy for Leukemia and Lymphoma
- Chronic Hepatitis C (HCV)
- Chronic Iron Overload
- Chronic Plaque Psoriasis
- Complement Inhibitors
- Corlanor (Ivabradine)
- Crohn’s Disease and Ulcerative Colitis
- Cromolyn Sodium Oral Solution
- Cryopyrin-Associated Periodic Syndromes (CAPS)
- Cryosurgical Ablation (Cryosurgery) of Primary or Metastatic Liver Tumors
- Crysvita (burosumab-twza)
- Cuprimine
- Cystic Fibrosis
- Cytochrome P450 Genotype-Guided Treatment Strategy
- Daptomycin
- Diagnosis and Treatment of Sacroiliac Joint Pain
- Digital Health Therapies for Attention Deficit/Hyperactivity Disorder
- Dojolvi (triheptanoin)
- DPP-4 Inhibitors and Combinations
- Duchenne Muscular Dystrophy (DMD)
- Dupixent
- Edarbi (azilsartan)
- Emsam (selegiline)
- Enhertu (fam-trastuzumab derutecan-nxki)
- Entresto (Sacubitril/Valsartan)
- Epoetin Alfa (Procrit®, Epogen®) Darbepoetin Alfa (Aranesp®)
- Eucrisa (crisaborole)
- Evenity (romosozumab-aqqg)
- Evoxac (cevimeline)
- Facet Arthroplasty
- Felbatol (felbamate)
- Fetroja (cefiderocol sulfate tosylate)
- Gabitril (tigabine hydrochloride)/Peganone (ethotoin tablets)
- Gepants
- Giant Cell Arteritis
- Givlaari (givosiran sodium)
- GLP 1 Agonist
- Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
- Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
- Hematopoietic Cell Transplantation for Autoimmune Diseases
- Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia
- Hematopoietic Cell Transplantation for CNS Embryonal Tumors and Ependymoma
- Hematopoietic Cell Transplantation for Epithelial Ovarian Cancer
- Hematopoietic Cell Transplantation for Hodgkin Lymphoma
- Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in Adults
- Hematopoietic Cell Transplantation for Non-Hodgkin Lymphomas
- Hematopoietic Cell Transplantation for Primary Amyloidosis or Waldenstrom’s Macroglobulinemia
- Hematopoietic Cell Transplantation for Solid Tumors of Childhood
- Hematopoietic Cell Transplantation in the Treatment of Germ Cell Tumors
- Hematopoietic Stem-Cell Transplantation for Breast Cancer
- Hemophilia Factor VIII Factor IX Factor X
- Hereditary Angioedema (HAE)
- Hidradenitis Suppurativa (HS)
- Hormone Pellet Implantation for Hormone Replacement Therapy (HRT) in Women
- Human Chorionic Gonadotropin (Pregnyl®, Novarel®, Ovidrel®)
- Human Growth Hormone and Insulin-like Growth Factor-1
- Idiopathic Pulmonary Fibrosis
- Impavido (miltefosine)
- Influenza Vaccine
- Inhaled Antibiotics for Cystic Fibrosis
- Injectable Asthma Agents
- Insulins (Non-Long Acting Products)
- Interferon alfa-2b (Intron A)
- Interferon alfa-n3 (Alferon N)
- Interferon Gamma-1b (Actimmune®)
- Intra-articular Hyaluronan Injections for Osteoarthritis
- Intravitreal Angiogenesis Inhibitors for Retinal Vascular Conditions
- Isotretinoin Products
- Isturisa (osilodrostat)
- IV Oncology
- Jynarque (tolvaptan)
- Koselugo (selumetinib)
- KRAS Mutation Analysis in Non-Small Cell Lung Cancer
- KRAS, NRAS, and BRAF Variant Analysis in Metastatic Colorectal Cancer
- Krystexxa (pegloticase)
- Kuvan (sapropterin)
- Laboratory and Genetic Testing for Use of 5-Fluorouracil in Patients With Cancer
- Laboratory Testing for HIV Tropism
- Laboratory Tests for Heart Transplant Rejection
- Lacrisert
Click here to view the Blue Cross Blue Shield BCBS Mississippi Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.